Medicover - Public Comps and Valuation Multiples

Medicover Overview

About Medicover

Medicover AB is an international healthcare and diagnostic services, provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. The company offers its services through two segments; Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas in Germany, Romania, Poland, and Ukraine; and Healthcare Services offer high-quality care based on an Integrated Healthcare Model and Fee-For-Service in Poland, India, and Romania. It generates maximum revenue from the Healthcare Services segment. Geographically, it derives a majority of its revenue from Poland and also has a presence in Romania; Germany; Ukraine; India, and Other Countries.

Founded

1995

HQ

Employees

47.3K+

Website

medicover.com

Sectors

Hospitals & Clinics

Financials

LTM Revenue $30.3B

LTM EBITDA $4.8B

EV

$5.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Medicover Financials

As of November 2025, Medicover reported last 12-month revenue of $30.3B and EBITDA of $4.8B.

In the same period, Medicover generated $6.9B in LTM gross profit and $891M in net income.

See Medicover valuation multiples based on analyst estimates

Medicover P&L

In the most recent fiscal year, Medicover reported revenue of $222M and EBITDA of $29.4M.

Medicover expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Medicover valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$30.3B	XXX	$222M	XXX	XXX	XXX
Gross Profit	$6.9B	XXX	$47.6M	XXX	XXX	XXX
Gross Margin	23%	XXX	21%	XXX	XXX	XXX
EBITDA	$4.8B	XXX	$29.4M	XXX	XXX	XXX
EBITDA Margin	16%	XXX	13%	XXX	XXX	XXX
EBIT	$2.0B	XXX	$9.2M	XXX	XXX	XXX
EBIT Margin	7%	XXX	4%	XXX	XXX	XXX
Net Profit	$891M	XXX	$1.8M	XXX	XXX	XXX
Net Margin	3%	XXX	1%	XXX	XXX	XXX
Net Debt	XXX	XXX	$69.2M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Medicover including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $30.3B. EBITDA for the last twelve months was $4.8B. In the most recent fiscal year, Medicover achieved $222M in revenue and $29.4M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$30.3B	Analyst estimates available to subscribers	$222M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$6.9B	Analyst estimates available to subscribers	$47.6M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	22.8% gross margin	Analyst estimates available to subscribers	21.4% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$4.8B	Analyst estimates available to subscribers	$29.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	15.9% EBITDA margin	Analyst estimates available to subscribers	13.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$2.0B	Analyst estimates available to subscribers	$9.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	6.6% EBIT margin	Analyst estimates available to subscribers	4.1% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$891M	Analyst estimates available to subscribers	$1.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	2.9% net profit margin	Analyst estimates available to subscribers	0.8% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$69.2M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Medicover

This financial data table provides comprehensive performance metrics for Medicover, a company based in Sweden. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Medicover generated $30.3B in revenue over the last twelve months.
The company achieved $4.8B in EBITDA over the last twelve months.
Gross profit for the last twelve months was $6.9B.
Net income over the last twelve months reached $891M.

Fiscal Year Performance

In the most recent fiscal year, Medicover reported $222M in total revenue.
Fiscal year EBITDA was $29.4M.
The company maintained a gross profit margin of 21.4% in the most recent fiscal year.
EBITDA margin for the fiscal year was 13.2%.
Net profit margin reached 0.8% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Medicover. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Medicover Stock Performance

Medicover has current market cap of SEK 35.2B (or $3.7B), and EV of SEK 49.9B (or $5.3B).

Market Cap Evolution

Medicover Stock Data

As of December 4, 2025, Medicover's stock price is SEK 233 (or $25).

See Medicover trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$5.3B	$3.7B	XXX	XXX	XXX	XXX	$0.60

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Medicover Valuation Multiples

Medicover's trades at 23.9x EV/Revenue multiple, and 180.1x EV/EBITDA.

See valuation multiples for Medicover and 15K+ public comps

Medicover Financial Valuation Multiples

As of December 4, 2025, Medicover has market cap of $3.7B and EV of $5.3B.

Equity research analysts estimate Medicover's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Medicover has a P/E ratio of 45.9x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$3.7B	XXX	$3.7B	XXX	XXX	XXX
EV (current)	$5.3B	XXX	$5.3B	XXX	XXX	XXX
EV/Revenue	1.9x	XXX	23.9x	XXX	XXX	XXX
EV/EBITDA	12.0x	XXX	180.1x	XXX	XXX	XXX
EV/EBIT	28.9x	XXX	575.5x	XXX	XXX	XXX
EV/Gross Profit	8.4x	XXX	n/a	XXX	XXX	XXX
P/E	45.9x	XXX	2106.5x	XXX	XXX	XXX
EV/FCF	73.9x	XXX	357.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Medicover Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Medicover Margins & Growth Rates

Medicover's last 12 month revenue growth is 13%

Medicover's revenue per employee in the last FY averaged $5K, while opex per employee averaged $1K for the same period.

Medicover's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Medicover's rule of X is 48% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Medicover and other 15K+ public comps

Medicover Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	13%	XXX	276%	XXX	XXX	XXX
EBITDA Margin	16%	XXX	13%	XXX	XXX	XXX
EBITDA Growth	17%	XXX	304%	XXX	XXX	XXX
Rule of 40	28%	XXX	26%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	48%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$5K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$1K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	17%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial